multiple sclerosis Archives -

Janssen’s MS pill outshines Sanofi’s Aubagio in phase 3 trial

https://pharmaphorum.com/news/janssens-ms-pill-outshines-sanofis-aubagio-in-phase-3-trial/

https://pharmaphorum.com/news/novartis-strikes-marketing-deal-for-polpharmas-potential-tysabri-biosimilar/

Novartis looks set to repurpose cancer drug in MS after trial wins

https://pharmaphorum.com/news/novartis-looks-set-to-repurpose-cancer-drug-in-ms-after-trial-wins/

Tackling the remaining challenges of multiple sclerosis

https://pharmaphorum.com/r-d/views-analysis-r-d/tackling-the-remaining-challenges-of-multiple-sclerosis/

Novartis ups 2019 guidance after strong Q2

https://pharmaphorum.com/news/novartis-ups-2019-guidance-after-strong-q2/

Understanding Multiple Sclerosis

https://pharmaphorum.com/partner-content/understanding-multiple-sclerosis/

Novartis secures initial block on Gilenya generics in US

https://pharmaphorum.com/news/novartis-secures-initial-block-on-gilenya-generics-in-us/

Celgene gets MS blockbuster-in-waiting ozanimod back on track

https://pharmaphorum.com/news/celgene-gets-ms-blockbuster-in-waiting-ozanimod-back-on-track/

German Merck shows new data backing BTK drug evobrutinib in MS

https://pharmaphorum.com/news/german-merck-shows-new-data-backing-btk-drug-evobrutinib-in-ms/

Search